A Single-center Study of Setmelanotide in Patients with Prader- Willi Syndrome (RM-493-043)
This is a Phase 2, single-center, open-label study designed to assess the safety and efficacy of setmelanotide in patients with obesity due to Prader-Willi Syndrome (PWS) who are 6 to 65 years of age. Up to 20 patients are planned to be enrolled.…
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates
- Ages
- 6 Years - 65 Years
- Sexes
- All
Leptin/Adiponectin Ratio Study
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates
RM-493-042
This is an open-label extension study designed to evaluate the long-term safety and tolerability of continued setmelanotide treatment in male and female patients ≥2 years of age who have completed or transitioned from a previous study with…
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates
- Ages
- 2 Years - N/A
- Sexes
- All